ABOUT US

Who We Are

The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network was established as a key objective of the CRE-PF. We strive to enhance and support the conduct of pulmonary fibrosis clinical trials research in Australia and New Zealand to provide hope and improved outcomes for people living with pulmonary fibrosis.

We aim to be the first point of contact for patients living with pulmonary fibrosis, their carers and health professionals in Australasia to learn about and be linked into pulmonary fibrosis clinical trials.

We understand that research offers hope and undisputed benefits for people living with pulmonary fibrosis.

Our Vision

To be a leading Pulmonary Fibrosis Clinical Trials Network that will:

  • Facilitate the development of an optimal environment for the performance of high-quality clinical trials in Australia and New Zealand, leading to safe and effective therapies in pulmonary fibrosis.
  • Build and enhance Australasian and international collaborations with all stakeholders in clinical trial performance and participation.

Our Mission

To facilitate high-quality Australasian clinical trial activity in pulmonary fibrosis, thereby maximising local capacity for the development of therapies that reduce morbidity and mortality and enhance quality of life for people living with pulmonary fibrosis.

Our Objectives

  1. Expand the pulmonary fibrosis clinical trial portfolio.
  2. Engage with consumers to improve access to current information and increase awareness about pulmonary fibrosis clinical research in Australasia.
  3. Support trial access for those outside metropolitan areas.
  4. Enhance collaborations in pulmonary fibrosis clinical trials.
  5. Development of Australasian early-phase clinical trial units and upskilling of the clinical trials workforce.
  6. Development of novel approaches to shorten timelines and broaden the PF clinical trials pipeline.

For further information regarding our objectives and strategies, please download our Strategic Plan 2024-2028.